Silvia Montoro García

Title: The Innovative Contributions of Silvia Montoro García

Introduction

Silvia Montoro García is a notable inventor based in Guadalupe, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and patenting efforts. Her work focuses on the use of Imipramine as an inhibitor of Fascin1 overexpression, particularly in relation to colorectal cancer.

Latest Patents

Silvia holds a patent for "Imipramine for use as an inhibitor of Fascin1 overexpression." This invention addresses the overexpression of Fascin1, which is often associated with cancer, and provides a method for treating cancer by administering an effective amount of Imipramine. This approach is particularly relevant for colorectal cancer, showcasing her commitment to advancing cancer therapies.

Career Highlights

Throughout her career, Silvia has worked with esteemed organizations such as Fundación Universitaria San Antonio and Fundación para la Formación e Investigación Sanitarias. Her roles in these institutions have allowed her to contribute to significant research and development in the medical field.

Collaborations

Silvia has collaborated with notable colleagues, including Pablo Conesa Zamora and Horacio Perez Sanchez. These partnerships have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Silvia Montoro García's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. Her patent on Imipramine highlights her dedication to finding effective solutions for complex health issues.